BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Chapter 7, 11
SoCal Biotech AtheroNova (AHRO) and its Subsidiary File for Chapter 11 3/3/2015
Egenix Files for Chapter 11 Bankruptcy 1/14/2015
Dendreon Corporation (DNDN) Heads for Bankruptcy Auction Without $275 Million Minimum Bidder 1/2/2015
Struggling Tengion Inc. Files for Chapter 7 Bankruptcy Protection 12/30/2014
Troubled Dendreon Corporation (DNDN) Files For Chapter 11 Bankruptcy 11/11/2014
New York-Based SIGA Technologies, Inc. (SIGA) Files For Bankruptcy 9/17/2014
Bay Area's Affymax, Inc. (AFFY) To Dissolve 6/26/2014
Struggling Morrisville Pharma Vestiq Pharmaceuticals Files Chapter 7 Bankruptcy 5/7/2014
Signature Genomic Laboratories, LLC To Shut Doors By Mid-2014; Future Tests Halted At End Of Week 5/5/2014
MedLab Commences Voluntary Chapter 11 Proceedings 10/28/2013
Savient Pharmaceuticals, Inc. (SVNT) Files for Chapter 11, Seeks to Sell Assets for About $55 Million 10/15/2013
KV Pharmaceutical Completes Reorganization and Successfully Emerges From Chapter 11 With $375 Million Recapitalization 9/16/2013
HedgePath Pharmaceuticals Completes Reorganization Plan With Commonwealth Biotechnologies, Inc. (CBTE) 8/19/2013
Maxygen, Inc. (MAXY) Shareholders Agree to Liquidate and Dissolve the Company 8/13/2013
Maxygen, Inc. (MAXY) Announces Board Decision to Dissolve the Company 6/4/2013
Allon Therapeutics, Inc. Filing for Bankruptcy 5/30/2013
GenVec Inc. (GNVC) Board Votes to Dissolve Company 5/29/2013
Allenex AB: ONCOlog Has Filed for Bankruptcy 5/8/2013
Commonwealth Biotechnologies, Inc. (CBTE) Says It has Emerged From Chapter 11 4/18/2013
PolyMedix Inc. (PYMX.OB) of Radnor Files for Chapter 7 Bankruptcy Protection 4/2/2013
After Bankruptcy, PRACS Institute (Formerly known as Cetero Research) Lays Off Workers 3/26/2013
Biovest International, Inc. Files for Bankruptcy 3/8/2013
Battered Helicos BioSciences Corporation (HLCS) Files for Chapter 11 11/16/2012
Myrexis, Inc. (MYRX) to Dissolve the Company and Liquidate Assets 11/13/2012
Inspiration Biopharmaceuticals Files for Chapter 11 10/31/2012
Nutra Pharma Corp. (NPHC) Faces Involuntary Bankruptcy 9/5/2012
KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes 8/6/2012
After a Long Fight to Survive, Genta Incorporated (GETA.OB) Files for Chapter 7 8/2/2012
Biolex Therapeutics Execs Gone Before Filing for $38 Million Bankruptcy 7/9/2012
"Corrupt" Lab Practices Pushes CRO Firm Cetero Research Into Bankruptcy 3/26/2012
Neurologix, Inc. Files to Liquidate Under Chapter 7 Bankruptcy 3/19/2012
Laboratories Thissen SA Files for Bankruptcy 11/16/2011
Simulations Plus (SLP) Submits Bid in Chapter 11 Bankruptcy Proceedings for Assets of Entelos, Inc. 9/20/2011
Transdel Pharmaceuticals, Inc. (TDLP.OB) Files for Chapter 11, Agrees to Sell Lead Drug Candidate to Cardium Therapeutics, Inc. (CXM) 6/28/2011
Hawaii Biotech, Inc. Exits Bankruptcy 6/21/2011
Molecular Insight Pharmaceuticals, Inc. (MIPI) Announces Confirmation of Plan of Reorganization 5/9/2011
Advanced Life Sciences Holdings, Inc. (ADLS) Suspends Operations 5/6/2011
Ambrilia Biopharma Inc. Announces That it Will Seek Permission to Terminate CCAA Protection and File for Bankruptcy 4/8/2011
Peptimmune, Inc. Files Under Chapter 7 3/23/2011
Molecular Insight Pharmaceuticals, Inc. (MIPI) Accepts Alternative Transaction Proposal and Files Amended Plan of Reorganization 3/9/2011
MetaMorphix Announces Sale Under Bankruptcy Code 2/7/2011
Isis Pharmaceuticals, Inc. (ISIS) Spinoff Altair Therapeutics Shut Down After Mid-Stage Asthma Study Fails 2/4/2011
Angiotech Pharmaceuticals, Inc. (ANPI) Announces U.S. Chapter 15 Filings in Connection with Previously Announced CCAA Proceedings 2/1/2011
Molecular Insight Pharmaceuticals, Inc. (MIPI) Faces Uncertain Future in Chapter 11 1/31/2011
Canada's Angiotech Pharmaceuticals, Inc. (ANPI) to File for Bankruptcy 1/28/2011
Molecular Insight Pharmaceuticals, Inc. (MIPI) Files for Chapter 11 After Bondholders Reject $45 Million Rescue Package from Savitr Capital LLC 12/10/2010
Accentia, Inc., Biovest International, Inc. Emerges from Chapter 11 Reorganization 11/17/2010
Accentia Biopharmaceuticals (ABPI), Biovest International, Inc. Announces Confirmation of Plan of Reorganization As It Emerges From Chapter 11 10/28/2010
Surefil LLC Emerges from Chapter 11 9/23/2010
ConjuChem Biotechnologies Inc. (CJB.TO) Announces Bankruptcy Act Filing; Directors and Officers of Company Resign 7/22/2010
AutoImmune, Inc. (AIMM) Files Certificate of Dissolution and Completes Sale of Colloral LLC Business; Trading of Common Stock to Cease After June 30, 2010 7/1/2010
Neose Technologies, Inc. (NTEC) Announces Final Liquidating Distribution 6/10/2010
Exiqon A/S is Closing Down Operations at Oncotech 6/7/2010
Accentia, Inc. Files Plan of Reorganization; Restructuring Supports Plans to Advance Promising Multiple Sclerosis Therapy into Late-Stage Clinical Trial 6/1/2010
Cobalis Corp. (CLSC.PK) Files Form of Order with US Bankruptcy Court Signaling Emergence from Bankruptcy 5/26/2010
TLC Vision Corp. (TLC) Completes Financial Restructuring; Emerges From Chapter 11 as Newly Reorgnized Private Company 5/20/2010
Biovest International, Inc. Files Plan of Reorganization; Company Positioned to Emerge from Chapter 11 This Summer Fully Restructured 5/17/2010
MiddleBrook Pharmaceuticals, Inc. Files for Bankruptcy 5/3/2010
U.S. Federal Bankruptcy Court Confirms Cobalis Corp. (CLSC.OB)'s Plan of Reorganization 4/12/2010
Haemacure Corporation (HAE) Gets Canada Court OK to Sell Assets to Angiotech Pharmaceuticals, Inc. (ANPI) 3/22/2010
Neuropharm Group plc to Mull Voluntary Liquidation to Return Cash 3/10/2010
AutoImmune, Inc. (AIMM) Announces Board Approval of Plan of Complete Liquidation and Dissolution 3/9/2010
Announcing the New deCODE genetics, Inc. (DCGN); Company Emerges from Bankruptcy 1/25/2010
Luna Innovations Inc. Emerges from Chapter 11 Reorganization 1/13/2010
Anesiva, Inc. (ANSV) Says to Seek Bankruptcy After Deal Fails 1/4/2010
Vion Pharmaceuticals (VION) Files for Chapter 11 Bankruptcy After FDA Rejects Drug 12/18/2009
Hawaii Biotech, Inc. Files for Bankruptcy 12/15/2009
deCODE genetics, Inc. (DCGN) Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 11/17/2009
Altus Pharmaceuticals Inc. (ALTU) Files for Chapter 7 Bankruptcy 11/12/2009
Nyer Medical Group, Inc. (NYER) Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors; Nyer to Liquidate Following Transactions 10/26/2009
La Jolla Pharmaceutical Company (LJPC) to Seek Stockholders' Approval of Dissolution 10/15/2009
Altus Pharmaceuticals Inc. (ALTU) to Shut Doors; Firm to Let Go of Employees by October 9/18/2009
Protein Sciences Corporation: Bankruptcy Court Delaware Dismisses Involuntary Bankruptcy Case 9/15/2009
Neurobiological Technologies, Inc. (NTII) Board Approves Liquidation Plan 9/1/2009
La Jolla Pharmaceutical Company (LJPC) Plans Liquidation 8/5/2009
Ambrilia Biopharma Inc. to File for Creditor Protection 7/31/2009
Argolyn Bioscience, Inc.'s Final Failure; Company in Chapter 7 Bankruptcy Dissolution 7/27/2009
Luna Innovations Inc. Files for Chapter 11 Reorganization 7/17/2009
Biopure Corporation (BPUR) Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code 7/17/2009
Oscient Pharmaceuticals Corporation (OSCI) Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million 7/14/2009
TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust 7/10/2009
Isolagen, Inc. (ILE) Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 6/22/2009
EDEN Bioscience (EDEN) Announces Voluntary Delisting From Nasdaq and Filing of Articles of Dissolution 6/19/2009
US Biotech Isolagen, Inc. (ILE) Files for Bankruptcy Protection 6/16/2009
Northstar Neuroscience, Inc. Announces Plan for NASDAQ Delisting and Filing of Articles of Dissolution 6/12/2009
Genaera Corporation (GENR) Board Votes to Dissolve Company 6/12/2009
Northfield Laboratories (NFLD) to Liquidate Under Chapter 11 6/2/2009
TorreyPines Therapeutics, Inc. (TPTX) Board Approves Liquidation 6/1/2009
EDEN Bioscience (EDEN) Announces Shareholders' Approval of Plan of Dissolution and Liquidation 5/21/2009
Prospect Therapeutics, Inc. Assigns All Its Assets for the Benefit of Its Creditors 5/13/2009
Northfield Laboratories (NFLD) Terminates All of its Operational and Staff Employees and Shuts Down 5/11/2009
Targeted Genetics Corporation (TGEN), Mainstay of Gene Therapy, Faces Likely Shutdown 5/8/2009
Genaera Corporation (GENR) Shutting Down; Company Announces Approval of Plan of Liquidation and Dissolution by Board of Directors 4/30/2009
PharmEng (PII.V) Unable to File Its 2008 Audited Annual Financial Statements and Closes Sydney Manufacturing Facility 4/23/2009
PharmEng (PII.V) Has Filed Notice of Intention to Make a Proposal Under the Bankruptcy & Insolvency Act (Canada) 4/15/2009
Drug Company DiObex, Inc. Shutting Down 4/8/2009
DelSite, Inc. Announces Bankruptcy Filing 4/3/2009
Codon Devices Closing As Financing Dwindles 4/3/2009
Avigen, Inc. (AVGN) Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation 3/26/2009
Neose Technologies, Inc. (NTEC) Announces Initial Liquidating Distribution to Stockholders; Provides New Contact Information for Stockholder Inquiries 3/16/2009
Apex Bioventures Acquisition Corporation (PEX): To Seek Stockholder Approval To Liquidate and Dissolve 3/6/2009
Dynogen Pharmaceuticals, Inc. Files for Bankruptcy 2/25/2009
Vanda Pharmaceuticals, Inc. (VNDA) to Fight Shareholder Liquidation Proposal 2/24/2009
AtheroGenics (AGIX) Provides Update on Bankruptcy Proceedings 1/22/2009
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy 1/22/2009
Biotech Startup, Flex Biomedical Inc. CEO Says Massachusetts Exit Could be the Best Move 1/2/2009
MonoGen Inc. Announces Assignment and Filing for the Benefit of Creditors 1/2/2009
Chemokine Therapeutics Corp. (CTI.TO) Announces Intention to File a Proposal to Creditors Under Bankruptcy and Insolvency Act 12/8/2008
EDEN Bioscience (EDEN) Announces Board of Directors' Approval of Plan of Dissolution and Liquidation 12/5/2008
Introgen Therapeutics, Inc. (INGN) Files for Bankruptcy, Sees Exit in 2009 12/4/2008
'Unprecedented' Biotech Bankruptcies Erupt Amid Finance Crisis 11/21/2008
MicroIslet Inc. (MII) Announces Voluntary Reorganization Filing; Company Expects Operations to Continue as Usual 11/11/2008
Xechem International (XKEM) and Xechem, Inc. Files Chapter 11 to Protect Assets as It Addresses Financial and Legal Challenges 11/10/2008
Chad Therapeutics, Inc. (CTU) Suspends Operations 10/29/2008
Life Science Weekly inSite (Oct. 13 - 16) 10/17/2008
Carlsbad Biotech Company, Orchestra Therapeutics (OCHTZ) Files Bankruptcy 10/16/2008
Life Science Weekly inSite (Oct. 6 - 10) 10/13/2008
AtheroGenics (AGIX) Files for Chapter 11 Bankruptcy 10/7/2008
Mistral Pharma Inc.: The Court Approves the Proposal Filed Under the Bankruptcy and Insolvency Act 9/18/2008
POINT Biomedical Corporation's Vanishing Act -- What Happened? 8/27/2008
Cash or Perish, Adherex Technologies Inc. (ADH) Warns Investors 8/25/2008
Mistral Pharma Inc. Files a Proposal Under the Bankruptcy and Insolvency Act 8/20/2008
Immunicon Corporation (IMMC) Files for Chapter 11 Bankruptcy 6/11/2008
Point Therapeutics (POTP) May File for Chapter 11 2/4/2008
Synova Healthcare Inc. Files Voluntary Petition to Reorganize Under Chapter 11 12/19/2007